Martin Schütz
About Martin Schütz
Martin Schütz is the Medical Director Oncology - Lung, H&N and Pediatric at Bristol Myers Squibb in Munich, Bavaria, Germany. He has extensive experience in oncology, having held multiple roles at Bristol Myers Squibb and has a diverse educational background in genetics, cell biology, and molecular biology.
Title: Medical Director Oncology
Martin Schütz currently holds the title of Medical Director Oncology focusing on Lung, Head and Neck (H&N), and Pediatric at Bristol Myers Squibb. His professional role is based in Munich, Bavaria, Germany. This position highlights his extensive experience and responsibilities within the oncology sector at a leading global biopharmaceutical company.
Career at Bristol Myers Squibb
Martin Schütz has held multiple positions at Bristol Myers Squibb, demonstrating a progressive career path within the company. Starting as a Medical Science Manager in 2013, he advanced to the role of Medical Advisor Oncology in 2015, a position he held for four years. In 2019, he transitioned to Associate Medical Director Oncology and after two years, moved to his current role as Medical Director Oncology. His decade-long tenure at Bristol Myers Squibb underscores his significant contributions and expertise in the field of oncology.
Co-Founder of BIOcomuniCA'T
Martin Schütz co-founded BIOcomuniCA'T, a science communication initiative, and served in this role from 2011 to 2013 in Barcelona. This initiative focuses on conveying scientific knowledge and research findings to the broader public. His work in this capacity reflects his commitment to science communication and education.
University Education and Research
Martin Schütz boasts a diverse educational background, having studied Genetics, Cell Biology, Organic Chemistry, Pharmacie, Biomedicina, and Cell/Cellular and Molecular Biology. He earned a Master of Biomedical Research and a PhD from Universidad Pompeu Fabra. Additionally, he studied at institutions such as the University of Cambridge, Université René Descartes (Paris V), and University of Regensburg. His academic journey is marked by extensive research experience, including roles as a Predoctoral Researcher at the University of Cambridge and Center for Genomic Regulation (CRG).
Industry and Academic Experience
Martin Schütz has accumulated valuable experience in both academic and industry settings. His academic roles include being a PhD Candidate and Post-Doc at the Center for Genomic Regulation (CRG) in Barcelona. On the industry side, his various roles at Bristol Myers Squibb highlight his expertise and leadership in the oncology field. This blend of academic research and industry practice positions him uniquely in the medical research and biopharmaceutical landscapes.